IAPP and Alzheimer disease: At high concentration of human amylin, these polypeptides activated the TRPV4 channel, which subsequently depolarized the local membrane and allowed a high calcium influx into the cells resulting in neuronal dysfunction, inflammation, and neurotoxicity, thereby making TRPV4 a therapeutic interest for treating AD pathology [193].